Chinese Vaccine Firms Forecast Plunging Profit

Competition, Economy Major Factors

Tower
Slumps in annual profits for 2024 have become a consensus among Chinese vaccines makers. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Focus On Asia